This is an actor representation of a hypothetical patient profile that was developed for educational purposes based on characteristics of patients with ALK+ non-small cell cancer, as can be seen in clinical practice. The hypothetical case was jointly developed by medical authors by employees with Cancer Network/Onn.
- Dr. Escape asks Dr. Garon: How would you describe the current treatment landscape for metastatic Alk+ NSCLC?
- Which other treatment options could have been considered for this patient?